LABRYS BIOLOGICS, INC.

Profile

Company Names

LABRYS BIOLOGICS, INC.

Addresses

1700 OWENS STREET, SUITE 595, SAN FRANCISCO, CA 94158

Phone Numbers

415-800-0800

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$14,588,234.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-12-21 
$14,588,234.00 
$30,999,997.00 
$16,411,763.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
COREY 
 
GOODMAN 
EXECUTIVE OFFICER, DIRECTOR
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
WENDE 
 
HUTTON 
DIRECTOR
TRANSCEND MEDICAL INC   |  APIERON INC   |  CALIBRA MEDICAL, INC.   |  THERACLONE SCIENCES, INC.   |  REVISION OPTICS INC   |  ALTHEOS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  MATURE WOMEN-S HEALTH SOLUTIONS, INC.   |  DERMIRA, INC.   |  LABRYS BIOLOGICS, INC.   |  BUTTERFLY HEALTH, INC.   |  CHRONO THERAPEUTICS INC.   |  MINIMALLY INVASIVE DEVICES INC.   |  HERA THERAPEUTICS INC.   |  ONCORESPONSE INC   |  HYALEX ORTHOPAEDICS, INC.   |  QLARIS BIO, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  GLOOKO, INC.   |  ALCHERA INC   |  ANTIVA BIOSCIENCES, INC.   |  ONCORESPONSE, INC
STEVE 
P. 
JAMES 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
LABRYS BIOLOGICS, INC.
NINA 
S. 
KJELLSON 
DIRECTOR
TRIUS THERAPEUTICS INC   |  LABRYS BIOLOGICS, INC.
MICHAEL 
F. 
POWELL 
DIRECTOR
ANESIVA, INC.   |  INTELLIKINE, INC.   |  LABRYS BIOLOGICS, INC.   |  OCERA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#